Aptamer Group pursues a variety of partnerships across the life sciences ecosystem, leveraging our Optimer® platform to deliver new solutions that enable scientific breakthroughs.
When success is critical, we are the partner of choice.
From global biopharma and leading academic institutions to specialised manufacturers and charitable research organizations, we've cultivated long-term partnerships grounded in scientific rigor and mutual success.
Optimer® binders deliver precise biomarker targeting with engineered kinetics, tunable half-life, and superior tissue penetration, expanding what’s therapeutically possible.
We partner with biotherapeutic developers to leverage our platform’s capabilities and develop targeted treatments:
A selection of our work with biotherapeutic partners
The future of diagnostics demands better tools. Optimer® binders unlock previously inaccessible biomarkers and deliver assay-ready performance that accelerates development timelines to improve patient outcomes.
We partner with test developers to advance development with critical tools for a range of assay types, including IHC, LFD, ELISA, and biosensors.
A selection of our work with diagnostic partners
Research demands reliability. Optimer® binders enable researchers to hit new targets and build better assays. With batch-to-batch consistency, exceptional stability, and performance across diverse conditions they are empowering researchers with tools they can trust.
From matched pairs to IHC reagents and enzyme inhibitors to novel applications in cosmetics we work across a broad range of industries to deliver better performance.
A selection of our work with partners for reagents
